Category Archives: Female Health
Stem Cell Breast Reconstruction: Safety, Risks, & Side Effects
New stem-cell enhanced breast reconstruction: Ground-breaking or risky? Breast cancer is the most common form of cancer in women and a good number of women will suffer from it in their lifetime. In the United States, 200,000 women are diagnosed each year with this cancer, and a fourth of them will go on to die [...]
NuvaRing Blood Clot Risks & Side Effects: Is It Safe for You to Use?
Are you thinking about using the NuvaRing, the birth control vaginal ring? If so, take note: health experts say that women wanting to use NuvaRing because of its effectiveness and convenience must balance these qualities against the fact that the contraceptive may pose a higher risk for blood clots.
Vaginal Mesh Implants: Safety and Side Effects Study Ordered by FDA
If you’re a woman and you suffer from urinary incontinence, take heed.
The United States Food and Drug Administration recently issued an order requiring makers of implantable surgical mesh used to treat urinary incontinence in women to study the rates of organ damage and complications linked to vaginal mesh implants.
What Happens When PIP Breast Implants Break or Leak?
[/caption]Does the current ‘global’ scare over French breast implants affect you? Yes, it does affect you, if you are one of 300,000 to 400,000 women in any of the 65 countries whose surgeon used a silicone implant made by the French company Poly Implant Prothese (PIP).
And yes, the issue does affect you if are one of almost 300,000 American women or 1.5 million women worldwide who have had a breast augmentation in 2010, or among the countless more who have had this procedure between 2005 and 2010.
Ortho Evra Blood Clot Risks and Other Side Effects & Adverse Reactions
Reproductive health advisers to the United States Food and Drug Administration have recommended that the label of Johnson & Johnson’s birth control patch Ortho Evra be simplified to explain the risk of blood clots more clearly.
Voting 20 to 3 with one abstention, the panel said the current label for Ortho Evra inadequately reflects the risks women face by using it.
